Changing aspects of sevoflurane in paediatric anaesthesia: 1975-99.
Holzki
J
J
Kretz
F J
FJ
D017109:Akathisia, Drug-Induced / Q000209:etiology; D000769:Anesthesia, Inhalation; D018685:Anesthetics, Inhalation / Q000008:administration & dosage* / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003693:Delirium / Q000139:chemically induced; D004987:Ethers / Q000009:adverse effects; D006221:Halothane / Q000008:administration & dosage; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000009:adverse effects; D008738:Methyl Ethers / Q000008:administration & dosage* / Q000009:adverse effects; D009609:Nitrous Oxide / Q000008:administration & dosage; D012640:Seizures / Q000139:chemically induced; D000077149:Sevoflurane; D013997:Time Factors
D018685:Anesthetics, Inhalation; D004987:Ethers; D006845:Hydrocarbons, Fluorinated; D008738:Methyl Ethers; D000077149:Sevoflurane; C078742:fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether; D009609:Nitrous Oxide; D006221:Halothane